The importance of lipid lowering and other risk reduction therapies for patients with cardiovascular disease

被引：0
|
作者：
Smith, SC [1 ]
机构：
[1] Univ N Carolina, Sch Med, Dept Cardiol, Chapel Hill, NC 27599 USA
来源：
AMERICAN JOURNAL OF MANAGED CARE | 1997年 / 3卷
关键词：
CORONARY-HEART-DISEASE; VENTRICULAR ENLARGEMENT TRIAL; ACUTE MYOCARDIAL-INFARCTION; PLAQUE DISRUPTION; CLINICAL-TRIALS; SURVIVAL; EVENTS; CARE; HYPERCHOLESTEROLEMIA; ASSOCIATION;
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：S30 / S38
页数：9
相关论文
共 50 条
  • [1] Access to Nonstatin Lipid-Lowering Therapies in Patients at High Risk of Atherosclerotic Cardiovascular Disease
    Knowles, Joshua W.
    Howard, William B.
    Karayan, Lala
    Baum, Seth J.
    Wilemon, Katherine A.
    Ballantyne, Christie M.
    Myers, Kelly D.
    CIRCULATION, 2017, 135 (22) : 2204 - 2206
  • [2] Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk
    Wilkins, John T.
    Lloyd-Jones, Donald M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (03): : 266 - 267
  • [3] Novel lipid-lowering therapies and cardiovascular risk management
    Rizzo, M.
    CARDIOLOGY, 2013, 126 : 26 - 26
  • [4] Reduction of cholesterol and other cardiovascular disease risk factors by alternative therapies
    Tappia, Paramjit S.
    Xu, Yan-Jun
    Dhalla, Naranjan S.
    CLINICAL LIPIDOLOGY, 2013, 8 (03) : 345 - 359
  • [5] Pemafibrate and other triglyceride-lowering therapies to reduce risk of cardiovascular and metabolic disease
    Miller, Michael
    CURRENT OPINION IN CARDIOLOGY, 2024, 39 (04) : 286 - 291
  • [6] PATIENTS' AND HEALTHCARE PROFESSIONALS' PREFERENCES REGARDING LIPID-LOWERING THERAPIES FOR PATIENTS WITH VERY HIGH CARDIOVASCULAR RISK AND ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
    Garcia, Parrondo F. J.
    Olmo, Fernandez M. R.
    Hermida, Alvarez A. B.
    Castellanos, M.
    Gomez, Cerezo J.
    Guaita, Igual M. J.
    Chaparro, Jansen S. J.
    Rebollar, Obaya J. C.
    Mitjana, Martin L.
    Cosin-Sales, J.
    VALUE IN HEALTH, 2023, 26 (12) : S448 - S448
  • [7] New Treatment Targets and Innovative Lipid-Lowering Therapies in Very-High-Risk Patients with Cardiovascular Disease
    Burger, Achim Leo
    Pogran, Edita
    Muthspiel, Marie
    Kaufmann, Christoph Clemens
    Jaeger, Bernhard
    Huber, Kurt
    BIOMEDICINES, 2022, 10 (05)
  • [8] Impact of Lipid Lowering Therapies on the Primary Prevention of Atherosclerotic Cardiovascular Disease
    Akruti P. Prabhakar
    Deepak Vedamurthy
    Dinesh K. Kalra
    Current Cardiovascular Risk Reports, 2025, 19 (1)
  • [9] Risk in cardiovascular disease - Merit of using risk reduction rather than absolute risk for lipid lowering drugs
    Neary, R
    Ramachandran, S
    BRITISH MEDICAL JOURNAL, 2000, 321 (7254): : 174 - 174
  • [10] Clinical Update on Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk
    Ray, Kausik K.
    Wright, R. Scott
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (21): : 2205 - 2205
12345